Icecure Medical Ltd (NASDAQ: ICCM) on Tuesday, plunged -0.89% from the previous trading day, before settling in for the closing price of $1.12. Within the past 52 weeks, ICCM’s price has moved between $0.48 and $1.57.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 33.95%. The company achieved an average annual earnings per share of 11.46%. With a float of $24.40 million, this company’s outstanding shares have now reached $54.78 million.
Considering the fact that the conglomerate employs 77 people, you should pay attention to its efficiency factor. In terms of profitability, gross margin is 43.71%, operating margin of -394.94%, and the pretax margin is -374.2%.
Icecure Medical Ltd (ICCM) Breakdown of a Key Holders of the stock
Observing investor behavior towards Medical Devices industry stocks is more important than anything else. The insider ownership of Icecure Medical Ltd is 55.46%, while institutional ownership is 0.36%.
Icecure Medical Ltd (ICCM) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.08 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 11.46% per share during the next fiscal year.
Icecure Medical Ltd (NASDAQ: ICCM) Trading Performance Indicators
Icecure Medical Ltd (ICCM) is currently performing well based on its current performance indicators. A quick ratio of 2.27 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 16.57.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.29, a number that is poised to hit -0.07 in the next quarter and is forecasted to reach -0.24 in one year’s time.
Technical Analysis of Icecure Medical Ltd (ICCM)
Compared to the last year’s volume of 0.57 million, its volume of 0.48 million showed lagged in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 80.89%. Additionally, its Average True Range was 0.08.
During the past 100 days, Icecure Medical Ltd’s (ICCM) raw stochastic average was set at 88.73%, which indicates a significant increase from 80.00% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 74.95% in the past 14 days, which was lower than the 81.28% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.7691, while its 200-day Moving Average is $0.8515. Nevertheless, the first resistance level for the watch stands at $1.1467 in the near term. At $1.1833, the stock is likely to face the second major resistance level. The third major resistance level sits at $1.2367. If the price goes on to break the first support level at $1.0567, it is likely to go to the next support level at $1.0033. Now, if the price goes above the second support level, the third support stands at $0.9667.
Icecure Medical Ltd (NASDAQ: ICCM) Key Stats
Market capitalization of the company is 60.80 million based on 45,620K outstanding shares. Right now, sales total 3,230 K and income totals -14,650 K. The company made 660 K in profit during its latest quarter, and -4,150 K in sales during its previous quarter.
